CoDa Therapeutics (NZ) Ltd co-locates research team in the IIB

As a partner in the Institute for Innovation in Biotechnology, CoDa Therapeutics (NZ) Ltd scientists gain full access to the research infrastructure and expertise in the School of Biological Sciences. The company focuses on the development and commercialisation of therapeutics for wound and tissue repair. The New Zealand based company works in parallel with its US sister company, CoDa Therapeutics Inc, which is based in San Diego and is responsible for drug product manufacture, financing, marketing and business development.